Home | Medicus Research

Afexa Announces Results of a Clinical Trial of Dilexaponan™ for Cholesterol Management

Mon, 01/30/2012 - 14:45

EDMONTON, ALBERTA--(Marketwire - Aug. 18, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX® - today announced promising results of a pilot clinical study investigating the effects of a new formulation, Dilexaponan™ (LIP-01) on cholesterol management. Dilexaponan is a proprietary polymolecular formulation isolated from botanical sources and developed and...

Mon, 01/30/2012 - 13:16

Brent Bauer, an internist at the Mayo Clinic, noticed something strange in recent years about the clinic’s arthritis patients. Some reported no longer needing their steroid medications after drinking a juice produced from an obscure fruit. Bauer began wondering whether there really is something to the mangosteen. This tropical berry is used in expensive supplement beverages sold through...

Thu, 01/26/2012 - 15:20

CRO Popsi Cube is using iPhones to track blood pressure data and send questionnaires to patients. France-based Popsi Cube is using technology created by Withings, a developer of health technology, to provide the service, called Popsicare. The system links a blood pressure monitor to an iPhone or iPad for handling of the data. "Popsicare allows for the integration and transmission of remotely...

Thu, 01/26/2012 - 12:02

Wondering if electronic informed consent is right for your clinical research study? My 2-part series will help you answer that question. Mitchell Parrish of Quorum IRB recently led a webinar about electronic informed consent, which included discussion of regulatory and other considerations. In this series, I summarize the information presented by Parrish, as well as provide some additional...

Fri, 01/06/2012 - 13:33

In the second part of this special series on global outsourcing trends NutraIngredients explores how the European Union nutrition and health claims regulation (NHCR) is impacting activity in the contract research organisation (CRO) sector. The controversial legislation is changing the relationship between nutrition science and food and food supplements marketing due to the fact so much nutrition...

Clinical trial success: Design and recruitment

Fri, 01/06/2012 - 13:32

Designing a clinical trial correctly from the beginning is the most important issue for success, while a ready supply of volunteers for natural product clinical trials takes the pressure off patient recruitment, says the CEO of a CRO. Speaking with NutraIngredients, Dr Jay Udani, CEO of Medicus Research, a California-based clinical research organisation (CRO) with expertise in natural products,...

Clinical trial success: Patient compliance

Fri, 01/06/2012 - 13:31

A good relationship with clinical trial participants is crucial in making sure they are compliant to the protocol of a study, says the CEO of a CRO. Speaking with NutraIngredients, Dr Jay Udani, CEO of Medicus Research, a California-based clinical research organisation (CRO) with expertise in natural products, explained that when it comes to compliance, the first and most important thing is...

Tue, 10/11/2011 - 21:07

Systemedicus has developed informed consent and patient compliance apps for iPads and iPods and is looking to license the tools to CROs and sponsors. Apps developed by Systemedicus, a spin-out from natural health products contract research organisation (CRO) Medicus, turn iPads and iPods into tools for a variety of clinical trial tasks. Medicus has been using the tools on its own clinical trials...

Thu, 09/22/2011 - 17:48

Establishing joint health benefits of natural products can be done without using diseased populations, says UCLA’s Dr Jay Udani. The joint health space is in good shape in most markets globally with (mostly supplement) sales sitting at about $2bn. Strong links have been established between certain marquee nutrients like glucosamine and chondroitin and joint health/osteoarthritis benefits in the...

Thu, 03/10/2011 - 07:00

As the Energy Drink category expands, it begs the question, how do you measure energy? Are we talking about physical work, mental energy, or chemical energy? Jay Udani, MD will review the relevant literature on energy drinks and other "energy" providing dietary supplement categories and discuss the ways in which these products can be tested in high quality clinical trials that will support...

Tue, 01/25/2011 - 11:49

Designing a clinical trial correctly from the beginning is the most important issue for success, while a ready supply of volunteers for natural product clinical trials takes the pressure off patient recruitment, says the CEO of a CRO. Speaking with NutraIngredients, Dr Jay Udani, CEO of Medicus Research, a California-based clinical research organisation (CRO) with expertise in natural products,...

Mon, 01/24/2011 - 07:00

The Top 5 Best Kept Secrets in Dietary Supplement Clinical Trials The session will cover the five most critical factors in the design of clinical trials for dietary supplements, and how to avoid the common mistakes that plague these studies. This will be an action-oriented presentation, and you will walk away with specific items that will significantly improve the quality of the design of your...

Fri, 01/21/2011 - 07:00

In the second part of this special series on global outsourcing trends NutraIngredients explores how the European Union nutrition and health claims regulation (NHCR) is impacting activity in the contract research organisation (CRO) sector. European nutrition science will go on, but will it earn health claims? The controversial legislation is changing the relationship between nutrition science and...

The secrets for clinical trials success

Wed, 10/27/2010 - 06:00

Increasing regulatory pressure around the globe is focusing attention on supporting the efficacy of ingredients and products. Dr Jay Udani, CEO of Medicus Research, gave us his 5 secrets for clinical trials success.At the recent SupplySide West show in Las Vegas, Dr Udani – also an associate clinical professor at UCLA – explained that companies can no longer piggy-back on the science of others,...

Thu, 10/21/2010 - 06:00

From 2002 to 2008, rates of diabetes rose 90%. “That’s staggering," said Dr. Jay Udani, CEO and medical director, Medicus Research LLC, during a presentation at SupplySide West. “The coming diabetes catastrophe has the potential to ruin lives and bankrupt medical systems." Fortunately, in addition to medication that can indeed help control diabetes after its onset, Udani says several food and...

Wed, 06/02/2010 - 11:25

Establishing joint health benefits of natural products can be done without using diseased populations, says UCLA's Dr Jay Udani.The joint health space is in good shape in most markets globally with (mostly supplement) sales sitting at about $2bn. Strong links have been established between certain marquee nutrients like glucosamine and chondroitin and joint health/osteoarthritis benefits in the...

Upcoming Presentations:

Our Affiliated Companies

News and Updates